selected publications
-
academic article
- APOE3. The New England journal of medicine. 390:2156-2164. 2024
- Resilience to autosomal dominant Alzheimer's disease in a Reelin-COLBOS heterozygous man.. Nature medicine. 29:1243-1252. 2023
- Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer's dementia.. Acta neuropathologica. 144:589-601. 2022
- Waning locus coeruleus integrity precedes cortical tau accrual in preclinical autosomal dominant Alzheimer's disease.. Alzheimer's & dementia : the journal of the Alzheimer's Association. 19:169-180. 2022
- Associations Between Brainstem Volume and Alzheimer's Disease Pathology in Middle-Aged Individuals of the Framingham Heart Study.. Journal of Alzheimer's disease : JAD. 86:1603-1609. 2022
- Olfactory Function and Markers of Brain Pathology in Non-Demented Individuals with Autosomal Dominant Alzheimer's Disease.. Journal of Alzheimer's disease : JAD. 88:721-729. 2022
- In vivo rate-determining steps of tau seed accumulation in Alzheimer's disease.. Science advances. 7:-. 2021
- Associations between subregional thalamic volume and brain pathology in autosomal dominant Alzheimer's disease.. Brain communications. 3:-. 2021
- The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomography.. Science translational medicine. 13. 2021
- Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer's disease: findings from the Colombia-Boston (COLBOS) biomarker study.. Alzheimer's research & therapy. 13:-. 2021
- Association of Midlife Depressive Symptoms with Regional Amyloid-β and Tau in the Framingham Heart Study.. Journal of Alzheimer's Disease. 82:249-260. 2021
- Neuroticism Is Associated with Tau Pathology in Cognitively Unimpaired Individuals with Autosomal Dominant Alzheimer's Disease.. Journal of Alzheimer's disease : JAD. 82:1809-1822. 2021